Roche
ROG.SW
#36
Rank
NZ$601.03 B
Marketcap
NZ$749.18
Share price
0.46%
Change (1 day)
50.77%
Change (1 year)

Market capitalization of Roche (ROG.SW)

Market cap: NZ$601.03 Billion

As of January 2026 Roche has a market cap of NZ$601.03 Billion. This makes Roche the world's 36th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Roche from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$601.03 B3.97%
2025NZ$578.09 B44.52%
2024NZ$400.02 B8.08%
2023NZ$370.09 B-9.47%
2022NZ$408.80 B-22.36%
2021NZ$526.52 B26.97%
2020NZ$414.68 B1.06%
2019NZ$410.33 B30.67%
2018NZ$314.02 B3.8%
2017NZ$302.54 B7.06%
2016NZ$282.58 B-18.88%
2015NZ$348.34 B17.82%
2014NZ$295.66 B2.02%
2013NZ$289.80 B-24.43%
2012NZ$383.47 B103.16%
2011NZ$188.75 B14.26%
2010NZ$165.19 B-19.39%
2009NZ$204.94 B-12.12%
2008NZ$233.21 B17.91%
2007NZ$197.78 B-9.83%
2006NZ$219.35 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$918.38 B 52.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$481.86 B-19.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$253.99 B-57.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$200.17 B-66.70%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$477.83 B-20.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$174.46 B-70.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Abbott Laboratories
ABT
NZ$374.94 B-37.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$311.04 B-48.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$103.76 B-82.74%๐Ÿ‡บ๐Ÿ‡ธ USA